Breast cancer in Nigeria: Is non-adherence to chemotherapy schedules a major factor in the reported poor treatment outcome?

Breast Journal

Volumn 16, Issue 2, 2010, Pages 206-207

  Adisa, Adewale O ^a   Gukas, Isaac D ^b   Lawal, Oladejo O ^a   Adesunkanmi, Abdul Rasheed K ^a  

^a OBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITALS COMPLEX   (Nigeria)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIARRHEA; DRUG WITHDRAWAL; HEALTH CARE POLICY; HEALTH INSURANCE; HISTOPATHOLOGY; HUMAN; LETTER; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NIGERIA; RELIGION; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; NIGERIA; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 77953559089     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00883.x     Document Type: Letter

References (12)

1. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004;6:229-239
2. Jatoi I, Miller AB. Why is breast-cancer mortality declining? Lancet Oncol 2003;4:251-254
3. Adesunkanmi AR, Lawal OO, Adelusola KA, Durosimi MA. The severity, outcome and challenges of breast cancer in Nigeria. Breast 2006;15:399-409.
4. Ihekwaba FN. Breast cancer in Nigerian women. Br J Surg 1992;79:771-775
5. Gukas ID, Jennings BA, Mandong BM, et al. Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. West Afr J Med 2005;24:209-213
6. Ikpatt OF, Kuopio T, Collan Y. Proliferation in African breast cancer: biology and prognostication in Nigerian breast cancer material. Mod Pathol 2002;15:783-789
7. Oluwatosin OA, Oladepo O. Knowledge of breast cancer and its early detection measures among rural women in Akinyele Local Government Area, Ibadan, Nigeria. BMC Cancer 2006;6:271.
8. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998;352:930-942
9. Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 2005;23:6639-6646
10. Early Breast Cancer Trialists' Collaborative Group, Clarke M, Coates AS, et al. Adjuvant chemotherapy in oestrogen-receptorpoor breast cancer: patient-level meta-analysis of randomised trials. Lancet 2008;371:29-40.
11. De Maio E, Gravina A, Pacilio C, et al. Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a singlecenter experience. BMC Cancer 2005;5:30.
12. Gukas ID, Mbah N. Terminal events in women dying of advanced breast cancer: improving the care for terminal breast cancer patients in Africa. Int J Surg 2005;3:117-119